| Updates in January |
| Update |
Peptide Classfication |
Last Update Time |
Update entry |
Annotate |
View |
| 1 |
γ-Glutamyl peptides |
Jan. 7th, 2022 |
52 |
Add new bioactive peptide category "γ-Glutamyl peptide". |
 |
| 2 |
Blood-brain barrier peptides |
Jan. 9th, 2022 |
12 |
Add new bioactive peptide category "Blood-brain barrier peptide". |
|
| 3 |
ACE-inhibitory peptides |
Jan. 10th, 2022 |
41 |
Add new reported bioactive sequences from articles. |
|
| 4 |
Anticancer peptides |
Jan. 12nd, 2022 |
5 |
Add new reported bioactive sequences from articles. |
|
| 5 |
DPP IV-inhibitory peptides |
Jan. 16th, 2022 |
25 |
Add new reported bioactive sequences from articles. |
|
| 6 |
Antihypertensive peptides |
Jan. 17th, 2022 |
9 |
Add new reported bioactive sequences from articles. |
|
| 7 |
Renin-inhibitory peptides |
Jan. 18th, 2022 |
2 |
Add new reported bioactive sequences from articles. |
|
| 8 |
Vasorelaxation peptides |
Jan. 18th, 2022 |
1 |
Add new reported bioactive sequences from articles. |
|
| 9 |
Antimicrobial peptides |
Jan. 18th, 2022 |
9 |
Add new reported bioactive sequences from articles. |
|
| 10 |
Antiviral peptides |
Jan. 19th, 2022 |
1 |
Add new reported bioactive sequences from articles. |
|
| 11 |
α-amylase inhibitory peptides |
Jan. 19th, 2022 |
9 |
Add new reported bioactive sequences from articles. |
|
| 12 |
α-glucosidase inhibitory peptides |
Jan. 19th, 2022 |
12 |
Add new reported bioactive sequences from articles. |
|
| 13 |
Immunomodulatory peptides |
Jan. 20th, 2022 |
14 |
Add new reported bioactive sequences from articles. |
|
| 14 |
Hypocholesterolemic peptides |
Jan. 20th, 2022 |
5 |
Add new reported bioactive sequences from articles. |
|
| 15 |
Mineral-binding peptides |
Jan. 20th, 2022 |
2 |
Add new reported bioactive sequences from articles. |
|
| 16 |
Antioxidative peptides |
Jan. 21st, 2022 |
61 |
Add new reported bioactive sequences from articles. |
|
| 17 |
Multifunctional peptides |
Jan. 28th, 2022 |
24 |
19 multifunctional peptides were obtained by using tool "Multi-cross". |
|